D. Hinds, D. Gibbons, N. Gunsoy, M. Stott-Miller, F. Albers
{"title":"在一项横断面(IDEAL)研究中,对重症哮喘患者的鉴定和描述的再分析:重度哮喘患者接受新生物疗法的资格","authors":"D. Hinds, D. Gibbons, N. Gunsoy, M. Stott-Miller, F. Albers","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5926","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":166649,"journal":{"name":"D22. REAL WORLD MEDICATION USE IN PULMONARY DISEASES","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Eligibility for Newer Biologic Therapies in Severe Asthma, Re-analysis of the Identification and Description of sEvere Asthma patients in a cross-sectionaL (IDEAL) Study\",\"authors\":\"D. Hinds, D. Gibbons, N. Gunsoy, M. Stott-Miller, F. Albers\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5926\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":166649,\"journal\":{\"name\":\"D22. REAL WORLD MEDICATION USE IN PULMONARY DISEASES\",\"volume\":\"12 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"D22. REAL WORLD MEDICATION USE IN PULMONARY DISEASES\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5926\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"D22. REAL WORLD MEDICATION USE IN PULMONARY DISEASES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5926","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Eligibility for Newer Biologic Therapies in Severe Asthma, Re-analysis of the Identification and Description of sEvere Asthma patients in a cross-sectionaL (IDEAL) Study